Skip to main content
GRDX logo

GridAI Technologies Corp. (GRDX) Stock Price & Analysis

GridAI Technologies Corp. (GRDX) — MoonshotScore 20/100 (Weak band), calculated Nov 22, 2026. Price $3.16 (-8.41%), as of the Nov 20, 2026 trading session; market cap $32.4M.

Educational signal · not a buy or sell recommendation · How to read this

$3.16 −$0.29 (-8.41%) Market Cap $32.4M

GridAI Technologies Corp. · GRDX · NASDAQ

GridAI Technologies Corp. is a clinical-stage biopharmaceutical company focused on developing targeted, non-systemic therapies for gastrointestinal diseases. Their pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide, representing their commitment to innovative treatments.

Price as of Nov 20, 2026

Key Statistics

20 of 100

MoonshotScore v2 · GridAI Technologies (GRDX)

Weak
Business Quality Poor (9)
Financial Safety Fragile (16)
Valuation Bubble (17)
Growth Durability Shrinking (10)
Momentum Quiet (59)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Bottom-tier quality, a fragile balance sheet and stalling growth, and it’s expensive on top — broad distress, a capital-preservation call, not a value entry. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Poor; Financial Safety: Fragile; Valuation: Bubble; Growth Durability: Shrinking; Momentum: Quiet.

  • quarterly revenue $85,876 (Q2 FY2026, quarter ended Jun 30, 2026)
  • EPS beat 5 of the last 8 reports
  • Altman Z -8.96 · Piotroski F 3

Holding back: weak fundamentals, balance-sheet strain, a rich price, soft growth

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for GRDX (58 recorded, newest six shown)
RecordedScoreBand
21Weak
21Weak
21Weak
19Weak
19Weak
19Weak

The score moved from 19 in the stored Nov 21, 2026 snapshot to 20 in the current publication computed Nov 22, 2026 (+1); the largest pillar moves were Momentum +7 and Valuation +3. This current publication is not yet represented in the immutable snapshot archive.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$3.16
Change on the day-8.41%
Market capitalisation$32.4M—
Shares traded on the day125.2K

Price & events

Other perspectives

Council score for GridAI Technologies (GRDX): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Negative
Financial Safety Negative
Valuation Negative
Growth Durability Negative
Momentum Neutral

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Negative
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Weak
Debt/Equity Strong
ROE Negative
Gross Margin Negative

Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 9, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 22, 2026, except a card that shows its own read date.

1 · What is it?

What is GridAI Technologies (GRDX), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. GridAI Technologies Corp. (GRDX) is listed on NASDAQ. In Q2 FY2026 it reported revenue of $85,876 and net income of -$13M. The market values it at $32.4M.

2 · Latest results

What do the latest results show for GridAI Technologies (GRDX)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $85,876. Against analyst estimates the company has EPS beat 5 of the last 8 reports.

Quarterly income statement — 3 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026$85,876-$13M-$2.01 (diluted)
Q1 FY2026$38,208-$4M-$0.82 (diluted)
Q4 FY2025$36,251-$3M-$0.73 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for GridAI Technologies (GRDX)?

Short answer · as of

What is holding it back is weak fundamentals, balance-sheet strain, a rich price, soft growth. The distress and quality screens read Altman Z -8.96 · Piotroski F 3. Trailing ratios: ROE -55.1% · ROA -49.5% · current ratio 0.16 · earnings yield -85.4% · free-cash-flow yield -30.4%.

Data-derived red flags

  • Financial-distress signal — its Altman Z-Score of -8.96 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-55.1%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
5 · Peer comparison

How does GridAI Technologies compare with its peers?

Short answer

GridAI Technologies's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Fennec Pharmaceuticals Inc. (FENC) Same industry, near in market value$13.09 Nov 20, 2026$462M92 5-pillar Nov 22, 2026
Zevra Therapeutics, Inc. (ZVRA) Same industry, near in market value$8.76 Nov 20, 2026$521M91 5-pillar Nov 22, 2026
Protalix BioTherapeutics, Inc. (PLX) Same industry, near in market value$2.90 Nov 20, 2026$245M90 5-pillar Nov 22, 2026
Rigel Pharmaceuticals, Inc. (RIGL) Same industry, near in market value$40.09 Nov 20, 2026$755M87 5-pillar Nov 22, 2026
Rallybio Corporation (RLYB) Same industry, near in market value$15.47 Nov 20, 2026$83.3M82 5-pillar Nov 22, 2026
ImmuCell Corporation (ICCC) Same industry, near in market value$10.92 Nov 20, 2026$99.3M82 5-pillar Nov 22, 2026
Oramed Pharmaceuticals Inc. (ORMP) Same industry, near in market value$3.57 Nov 20, 2026$155M72 5-pillar Nov 22, 2026
Compugen Ltd. (CGEN) Same industry, near in market value$1.84 Nov 20, 2026$174M70 5-pillar Nov 22, 2026
Pharming Group N.V. (PHAR) Same industry, near in market value$11.54 Nov 20, 2026$817M69 5-pillar Nov 22, 2026
Climb Bio, Inc. (CLYM) Same industry, near in market value$9.19 Nov 20, 2026$540M68 5-pillar Nov 22, 2026
MeiraGTx Holdings plc (MGTX) Same industry, near in market value$7.98 Nov 20, 2026$780M64 5-pillar Nov 22, 2026
SpyGlass Pharma, Inc. Common Stock (SGP) Same industry, near in market value$30.43 Nov 20, 2026$1.02B64 5-pillar Nov 22, 2026
GridAI Technologies (GRDX) — this page$3.16$32.4M20

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held GRDX in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported GRDX in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about GridAI Technologies (GRDX)?

Read these with our analysis →

GridAI Technologies Stock: Key Questions Answered

These answers are editorial: 1 of these 9 answers is drawn from the GRDX research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for GRDX?

GRDX carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. GridAI Technologies Corp. is a clinical-stage biopharmaceutical company focused on developing targeted, non-systemic therapies for gastrointestinal diseases.

Is GRDX a good stock to buy?

Stock Expert AI does not rate GRDX buy, sell or hold. GridAI Technologies Corp. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the GRDX stock price today?

The last price recorded for GridAI Technologies Corp. (GRDX), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What do analysts say about GRDX stock?

As a micro-cap, clinical-stage biopharmaceutical company, GridAI Technologies Corp. is not widely covered by analysts. Given its early stage and high-risk profile, valuation metrics are largely dependent on the potential success of its pipeline assets.

What are the key factors to evaluate for GRDX?

GridAI Technologies Corp. (GRDX) holds a MoonshotScore in the low range. No dividend is paid, which is common for clinical-stage biopharmaceutical companies that prioritize reinvesting earnings into research and development. Not financial advice.

How frequently does GRDX data refresh on this page?

GRDX's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven GRDX's recent stock price performance?

GridAI Technologies Corp. (GRDX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on targeted, non-systemic therapies. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider GRDX overvalued or undervalued right now?

GridAI Technologies Corp. (GRDX) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of GRDX?

Fractional-share availability for GridAI Technologies Corp. (GRDX) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 13 figures on this page — 7 from Financial Modeling Prep (FMP), 4 with no recorded source and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.